The expression level of TIM3, CTLA‐4, and PD‐1 was also significantly enriched in most T‐cell subpopulations in MSI‐like cancers compared to other MSS patients (supplementary material, Figures S6E and S7A–E). This evidence concerns the gene CTLA4 and cancer.